A multicenter observational study to develop the program for predicting therapeutic efficacy of immune checkpoint inhibitor with OXEI (OXygen saturaion Endoscopic Imaging)
Not Applicable
Recruiting
- Conditions
- esophageal cancer, gastric cancer
- Registration Number
- JPRN-UMIN000046871
- Lead Sponsor
- national cancer center hospital east
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Those who are deemed inappropriate by the investigator for some reason
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Correlation analysis of OXEI with clinical course and clinicopathological features
- Secondary Outcome Measures
Name Time Method